Related Experiment Videos

A methylenetetrahydrofolate reductase polymorphism is associated with expression of p16 in human lung cancer

H Kamiya1, K Kawakami, T Miyanaga

  • 1Department of Surgery I, Kanazawa University School of Medicine, Kanazawa 920-8641, Japan.

Oncology Reports
|June 19, 1998
PubMed

Insights

Methylenetetrahydrofolate reductase (MTHFR) gene variants may influence cancer risk by affecting the expression of the p16INK4 tumor suppressor gene. Folate metabolism impacts carcinogenesis through p16INK4 regulation.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme in folate metabolism.
  • Reduced MTHFR activity is linked to DNA hypomethylation and stability.
  • This epigenetic alteration may influence the expression of tumor suppressor genes like p16INK4.

Purpose of the Study:

  • To investigate the association between MTHFR gene polymorphism and p16INK4 expression.
  • To explore the role of folate metabolism in carcinogenesis via p16INK4.

Main Methods:

  • Genotyping of MTHFR polymorphisms (Ala/Ala, Ala/Aal, Val/Val).
  • Immunostaining to assess p16INK4 expression levels.
  • Statistical analysis of genotype-specific p16INK4 expression.

Main Results:

  • Observed frequencies for MTHFR genotypes: 21 Ala/Ala, 29 Ala/Aal, 7 Val/Val.
  • p16INK4 expression was 26.2% in Val/Val genotype versus 11.2% in other genotypes (p=0.46).
  • The observed difference in p16INK4 expression between genotypes was not statistically significant.

Conclusions:

  • Folate metabolism, influenced by MTHFR activity, may play a role in cancer development.
  • The study suggests a potential link between MTHFR variants and p16INK4 expression in carcinogenesis.
  • Further research is needed to elucidate the precise mechanisms.

Related Concept Videos